Question 1

What are the current analyst recommendations for Pfizer Limited?

Accepted Answer

25% of analysts recommend buying the stock. 75% recommend overweight. 0 recommend holding. 0 recommend underweight. 0 recommend selling.

Question 2

What were the most recent quarterly financial results for Pfizer Limited?

Accepted Answer

In its latest quarter, Pfizer Limited reported revenue of ₹6.57B, with earnings per share (EPS) of ₹44.7. These results missed market expectations.

Pfizer Limited

PFIZER.NS - INE182A01018